Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT04908566 · RECRUITING
Trial details
- NCT number
- NCT04908566
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2023-08-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.